StockData
Beam Therapeutics Inc. logo

Beam Therapeutics Inc. (BEAM) stock

BEAMNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/304% below fair value
$22.83−1.20 (-4.99%)

Close on Nov 13, 2026Market cap $2.36BP/E –Yield –

Beam Therapeutics statistics

78 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Feb 23, 2027 (estimated, before the open)
Last ex-dividend date
No dividends
Fundamentals through
Jun 30, 2026
Share price as of
Nov 13, 2026

Valuation ratiosIndustry

Market Cap
$2.36B
$272.32M
Enterprise Value
$1.26B
$146.23M
PS Ratio
15.11
3.66
PB Ratio
2.21
2.00
P/TBV Ratio
2.21
2.22

Enterprise valuationIndustry

EV / Sales
8.06
2.57

Share statisticsIndustry

Shares Change (YoY)
16.3%
10.8%
Shares Change (QoQ)
0.51%
0.50%
Float
100M
49M
Shares Held by Insiders
3.36%
11.7%
Shares Held by Institutions
105.9%
56.4%

Short sellingIndustry

Short Interest
26M
–
Short Interest Change
-0.61%
-0.80%
Short % of Float
26.1%
9.01%
Short % of Shares Outstanding
25.3%
6.30%
Days to Cover
13.69
5.15

Stock price statisticsIndustry

52-Week High
$38.26
–
52-Week Low
$20.23
–
20-Day Moving Average
$25.66
–
50-Day Moving Average
$25.15
–
200-Day Moving Average
$27.87
–
Average True Range (14)
$1.70
–
Price Change (1 Week)
-13.6%
-1.15%
Price Change (1 Month)
-7.68%
-4.87%
Price Change (3 Months)
-15.8%
-21.0%
Price Change (6 Months)
-18.3%
-20.6%
Price Change (YTD)
-17.6%
-23.6%
Price Change (1 Year)
4.39%
-22.4%
Price Change (3 Years)
-7.01%
-29.5%
Price Change (5 Years)
-75.2%
-77.9%
Average Volume (10 Days)
2M
–
Average Volume (20 Days)
2M
–
Average Volume (90 Days)
2M
–
Relative Volume
1.07
0.70
Relative Strength Index (14)
40.1
43.4
Volatility (1 Year)
72.5%
80.1%
Beta (5 Years)
1.99
1.07

MarginsIndustry

Operating Margin
-242.3%
-38.7%
Profit Margin
-54.7%
-31.6%
EBITDA Margin
-228.0%
-27.7%
FCF Margin
-238.9%
-9.56%

Returns on capitalIndustry

Return on Equity (ROE)
-8.06%
-49.9%
Return on Assets (ROA)
-6.15%
-40.6%
Return on Capital Employed (ROCE)
-29.0%
-37.9%

Financial positionIndustry

Current Ratio
14.57
3.30
Quick Ratio
14.84
2.39
Debt / Equity
0.09
0.49

GrowthIndustry

Revenue Growth (YoY)
158.9%
6.82%
Revenue Growth (3Y CAGR)
31.9%
2.25%
Revenue Growth (5Y CAGR)
466.3%
6.41%

EfficiencyIndustry

Asset Turnover
0.11
0.40
Revenue Per Employee
$305.35K
$429.29K
Profits Per Employee
-$167.18K
-$689.41K
Employee Count
511
74
WACC
14.7%
10.2%

Income statement (TTM)Industry

Revenue
$156.04M
$66.37M
Operating Income
-$378.02M
-$21.37M
Net Income
-$85.43M
-$22.35M
EBITDA
-$355.78M
-$17.21M
EPS (Diluted)
-$0.82
-$0.76

Balance sheetIndustry

Total Debt
$100.26M
$116.91M
Net Cash (Debt)
$1.10B
$17.76M
Net Cash Per Share
$10.65
$0.80
Equity (Book Value)
$1.07B
$53.89M
Book Value Per Share
$10.33
$1.50
Tangible Book Value
$1.07B
$27.13M
Working Capital
$1.10B
$79.99M

Cash flow (TTM)Industry

Operating Cash Flow
-$359.38M
-$12.38M
Capital Expenditures
-$13.39M
-$1.00M
Free Cash Flow
-$372.77M
-$18.21M
FCF Per Share
-$3.61
-$0.42

Dividends and yieldsIndustry

Earnings Yield
-3.62%
-21.8%
FCF Yield
-15.8%
-9.44%

Taxes and interestIndustry

Income Tax
$0
$73.00K

Scores and fair valueIndustry

Altman Z-Score
2.72
0.23
Piotroski F-Score
4
4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

PeriodBEAMS&P 500DifferenceBEAM per yearS&P 500 per year
1 month-6.5%-3.0%−3.5 pts
3 months-13.9%-2.8%−11.1 pts
Year to date-17.6%+11.5%−29.1 pts
1 year+5.4%+13.5%−8.1 pts
3 years+4.1%+77.7%−73.6 pts+1.3%+21.1%
5 years-75.2%+72.6%−147.8 pts-24.3%+11.5%
10 years-72.6%+308.2%−380.8 pts-12.2%+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

26M BEAM shares were sold short on Oct 30, 2026, down 0.6% from the previous report, or 26.13% of the shares available to trade. At recent volumes it would take 13.7 days to buy them back. Over the last 20 sessions, 61.4% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 202626,082,937-0.6%1,904,58113.7
Oct 15, 202626,243,605-4.7%1,858,41914.1
Sep 30, 202627,548,815+6.4%1,800,51815.3
Sep 15, 202625,884,796+0.3%2,056,78512.6
Aug 31, 202625,802,667+5.9%1,738,34814.8
Aug 14, 202624,374,054+3.7%1,515,88016.1
Jul 31, 202623,498,484+1.2%2,078,52011.3
Jul 15, 202623,215,449+1.5%2,599,4328.9
Jun 30, 202622,881,525-19.2%2,731,8368.4
Jun 15, 202628,309,079+31.9%1,991,10314.2
May 29, 202621,455,853-19.1%1,829,05511.7
May 15, 202626,515,763+26.6%2,109,79612.6

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?